Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers

CompletedOBSERVATIONAL
Enrollment

1,730

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

September 29, 2020

Study Completion Date

October 23, 2020

Conditions
PreeclampsiaHypertensionProteinuriaThrombocytopeniaRenal InsufficiencyImpaired Liver FunctionPulmonary Edema
Trial Locations (20)

11501

Winthrop Clinical Trials Center, Mineola

17822

Geisinger Medical Center, Danville

21287

Johns Hopkins Medicine, Baltimore

27705

Duke University, Durham

35294

Center of Research in Women's Health, Birmingham

37403

Regional Obstetrical Consultants, PC, Chattanooga

39216

University of Mississippi Medical Center, Jackson

45220

Good Samaritan Hospital, Cincinnati

46202

Indiana University Health Physicians Women's Health, Indianapolis

53226

Medical College of Wisconsin - Department of Obstetrics & Gynecology, Milwaukee

60611

Northwestern, Chicago

63111

Washington Univ School of Medicine - Dept of OB-GYN, St Louis

73104

University of Oklahoma, Oklahoma City

77030

UT Health Medical School, Houston

77555

University of Texas Medical Branch, Galveston, Galveston

78758

Austin Maternal Fetal Medicine, Austin

80045

University of Colorado, Aurora

84132

University of Utah Hospital, OB/GYN Dept., Salt Lake City

06520

Yale Medical, New Haven

27599-7516

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
lead

Progenity, Inc.

INDUSTRY

NCT02780414 - Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers | Biotech Hunter | Biotech Hunter